Table 2 Typical NPs platforms made by different materials for medical imaging
From: Nanoparticles: A New Approach to Upgrade Cancer Diagnosis and Treatment
NPs | Size (nm) | Targeting material | Cell line | Imaging technology | Ref |
|---|---|---|---|---|---|
MnO-TETT | 6.7 ± 1.2 | None | C6 glioma cells | Fluorescence/T1-MRI | [29] |
PLGA-mPEG | 151.1 ± 1.3 | cRGD | SKOV-3 cells | US | [30] |
USMO@MSNs | 30–50 | Dox | HeLa cells | MRI-guided chemotherapy | [31] |
OINPs | 300 | Folate | SKOV3 ovarian cancer cells | US/PA | [32] |
PEG-coated and Gd-loaded fluorescent silica | 125.5 ± 9.9 | YPSMA-1 | LNCaP and PC3 prostate cancer cells | MRI/fluorescence imaging | [33] |
SPIO/USPIO | 50 | None | 4T1 murine breast cancer cells | MRI/MPI | [34] |